1. Home
  2. APM vs DFLI Comparison

APM vs DFLI Comparison

Compare APM & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • DFLI
  • Stock Information
  • Founded
  • APM 2010
  • DFLI 2020
  • Country
  • APM United Kingdom
  • DFLI United States
  • Employees
  • APM N/A
  • DFLI N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • APM Health Care
  • DFLI Technology
  • Exchange
  • APM Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • APM 6.1M
  • DFLI 5.0M
  • IPO Year
  • APM 2018
  • DFLI N/A
  • Fundamental
  • Price
  • APM $0.99
  • DFLI $0.16
  • Analyst Decision
  • APM
  • DFLI Strong Buy
  • Analyst Count
  • APM 0
  • DFLI 1
  • Target Price
  • APM N/A
  • DFLI $1.50
  • AVG Volume (30 Days)
  • APM 92.1K
  • DFLI 21.9M
  • Earning Date
  • APM 07-07-2025
  • DFLI 08-13-2025
  • Dividend Yield
  • APM N/A
  • DFLI N/A
  • EPS Growth
  • APM N/A
  • DFLI N/A
  • EPS
  • APM N/A
  • DFLI N/A
  • Revenue
  • APM N/A
  • DFLI $51,496,000.00
  • Revenue This Year
  • APM N/A
  • DFLI $42.46
  • Revenue Next Year
  • APM N/A
  • DFLI $39.78
  • P/E Ratio
  • APM N/A
  • DFLI N/A
  • Revenue Growth
  • APM N/A
  • DFLI N/A
  • 52 Week Low
  • APM $0.46
  • DFLI $0.16
  • 52 Week High
  • APM $7.49
  • DFLI $9.00
  • Technical
  • Relative Strength Index (RSI)
  • APM 47.58
  • DFLI 27.27
  • Support Level
  • APM $1.01
  • DFLI $0.19
  • Resistance Level
  • APM $1.06
  • DFLI $0.23
  • Average True Range (ATR)
  • APM 0.10
  • DFLI 0.05
  • MACD
  • APM -0.02
  • DFLI -0.01
  • Stochastic Oscillator
  • APM 15.68
  • DFLI 4.81

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: